Leef Brands (LEEEF) Raw Materials (2024 - 2026)

Leef Brands (LEEEF) reported Raw Materials of $1.2 million for Q1 2026, up 34.35% sequentially from $889784.0 in Q4 2025.

Leef Brands (LEEEF) Raw Materials (2024 - 2026) Analysis & Trends

Leef Brands (LEEEF) has 3 years of Raw Materials data on file, last reported at $1.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Raw Materials changed N/A year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (changed N/A YoY), and the FY2025 full-year result was $889784.0, down 34.09% from the prior year.
  • Raw Materials advanced to $1.2 million in Q1 2026, from $889784.0 in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $1.3 million in Q4 2024 to a low of $889784.0 in Q4 2025.
  • A 3-year average of $1.1 million and a median of $1.2 million in 2026 frame the typical range for Raw Materials.
  • Peak annual rise in Raw Materials reached 34.09% in 2025, while the deepest fall reached 34.09% in 2025.
  • Tracing LEEEF's Raw Materials over 3 years: stood at $1.3 million in 2024, then plunged by 34.09% to $889784.0 in 2025, then jumped by 34.35% to $1.2 million in 2026.
  • Business Quant data shows LEEEF's Raw Materials at $1.2 million in Q1 2026, $889784.0 in Q4 2025, and $1.3 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Leef Brands 51.94 Mn 46.18 Mn 4.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.20 Mn
Dec 31, 2025 889,784.00
Dec 31, 2024 1.35 Mn